Published in Ann Intern Med on June 01, 1977
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest (1986) 5.72
Infection of Syrian hamsters with Lyme disease spirochetes. J Clin Microbiol (1984) 5.40
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol (1984) 3.27
Characterization of Borrelia burgdorferi strains isolated from Ixodes pacificus ticks in California. J Clin Microbiol (1987) 2.89
Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol (1990) 2.87
Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev (1999) 2.82
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol (1991) 2.71
Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun (1986) 2.55
Lyme arthritis appearing outside the United States: a case report from Switzerland. Br Med J (Clin Res Ed) (1981) 2.20
Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev (1988) 2.18
Coinfections acquired from ixodes ticks. Clin Microbiol Rev (2006) 2.11
Induction of lyme arthritis in LSH hamsters. Infect Immun (1988) 2.07
Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis (2014) 2.07
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother (1987) 1.98
Physical map of the linear chromosome of the bacterium Borrelia burgdorferi 212, a causative agent of Lyme disease, and localization of rRNA genes. J Bacteriol (1992) 1.96
Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun (1986) 1.94
Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol (1990) 1.88
Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol Rev (1991) 1.87
Thermoregulation of protein synthesis in Borrelia burgdorferi. Infect Immun (1990) 1.81
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74
How to diagnose and treat Lyme disease in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1992) 1.74
Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol (1984) 1.72
The clinical spectrum and treatment of Lyme disease. Yale J Biol Med (1985) 1.70
Identification and characterization of an endoflagellar antigen of Borrelia burgdorferi. J Clin Invest (1989) 1.68
Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun (1990) 1.67
Lyme disease: a growing threat to urban populations. Proc Natl Acad Sci U S A (1994) 1.66
Histopathology of Lyme arthritis in LSH hamsters. Am J Pathol (1989) 1.63
Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol (1985) 1.57
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun (1992) 1.55
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun (1994) 1.30
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen. Infect Immun (1992) 1.30
Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity. J Clin Invest (1995) 1.28
Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J Clin Invest (1979) 1.26
Human phagocyte interactions with the Lyme disease spirochete. Infect Immun (1984) 1.25
Distribution of Borrelia burgdorferi sensu lato in China. J Clin Microbiol (2010) 1.24
Distribution of tick-borne diseases in China. Parasit Vectors (2013) 1.20
Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologic findings. Yale J Biol Med (1985) 1.18
Lymphocytic meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a clinical and serological study of 18 cases. J Neurol Neurosurg Psychiatry (1987) 1.17
Geographic distribution of humans, raccoons, and white-footed mice with antibodies to Lyme disease spirochetes in Connecticut. Yale J Biol Med (1985) 1.16
The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol (2012) 1.16
Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect Immun (2001) 1.13
European erythema migrans disease and related disorders. Yale J Biol Med (1985) 1.11
From New to old England: the progress of Lyme disease. Br Med J (Clin Res Ed) (1987) 1.09
Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood. Infect Immun (1984) 1.08
Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol (1994) 1.08
Evaluation of a quantitative fluorescence immunoassay (FIAX) for detection of serum antibody to Borrelia burgdorferi. J Clin Microbiol (1987) 1.07
Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol (1994) 1.06
Isolation and transmission of the Lyme disease spirochete from the southeastern United States. Proc Natl Acad Sci U S A (1993) 1.05
Survey for Ixodes spp. and Borrelia burgdorferi in southeastern Wisconsin and northeastern Illinois. J Clin Microbiol (1991) 1.02
Infection in rabbits with the Lyme disease spirochete. Yale J Biol Med (1985) 1.01
Lyme disease. West J Med (1991) 0.99
Immunoserology of infectious diseases. Clin Microbiol Rev (1990) 0.99
Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity. J Clin Invest (1997) 0.98
Lyme borreliosis and skin. Indian J Dermatol (2013) 0.96
Range of atrioventricular conduction disturbances in Lyme borreliosis: a report of four cases and review of other published reports. Br Heart J (1990) 0.94
Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes. Infect Immun (1992) 0.92
Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete. Yale J Biol Med (1985) 0.92
Geographical distribution and density of Ixodes dammini (Acari: Ixodidae) and relationship to Lyme disease transmission in New Jersey. Yale J Biol Med (1985) 0.91
Evaluation of genetic divergence of borrelial isolates from Lyme disease patients in Hokkaido, Japan, by rRNA gene probes. J Clin Microbiol (1993) 0.91
The NIH-3 immunodeficient mouse is a model for Lyme borreliosis myositis and carditis. Am J Pathol (1992) 0.91
The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes. Yale J Biol Med (1985) 0.89
Laboratory diagnosis of Lyme disease: advances and challenges. Infect Dis Clin North Am (2015) 0.88
Lyme arthritis in southern England. Br Med J (Clin Res Ed) (1987) 0.86
Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi. J Biol Chem (2013) 0.86
Lyme disease in New Jersey outdoor workers: a statewide survey of seroprevalence and tick exposure. Am J Public Health (1990) 0.86
Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol (1990) 0.85
Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am (2015) 0.84
Immunohistochemical analysis of Lyme disease in the skin of naive and infection-immune rabbits following challenge. Infect Immun (2001) 0.83
Evidence for spirochetal origin of Sudeck's atrophy (algodystrophy, reflex sympathetic dystrophy). Arch Orthop Trauma Surg (1989) 0.83
Lyme disease in Canada? CMAJ (1986) 0.82
Multiple mononeuritis and radiculitis with erythema, pain, elevated CSF protein and pleocytosis (Bannwarth's syndrome). J Neurol Neurosurg Psychiatry (1983) 0.82
Epidemiologic features of Lyme disease in New York. Yale J Biol Med (1985) 0.81
2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts. Ann Rheum Dis (1993) 0.81
Lyme disease. A Canadian perspective. Can Fam Physician (1993) 0.81
Lyme disease in Minnesota: epidemiologic and serologic findings. Yale J Biol Med (1985) 0.81
Chronic Lyme disease: misconceptions and challenges for patient management. Infect Drug Resist (2015) 0.79
The search for Ixodes dammini and Borrelia burgdorferi in Nova Scotia. Can J Infect Dis (1992) 0.79
Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response. Am J Public Health (2012) 0.79
Close to home: a history of Yale and Lyme disease. Yale J Biol Med (2011) 0.78
Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview. Int J Gen Med (2012) 0.78
Resolution of Lyme arthritis, acute or prolonged: a new look. Inflammation (2000) 0.78
Lyme disease in northern California. West J Med (1983) 0.78
The Borrelia burgdorferi flaB promoter has an extended -10 element and includes a T-rich -35/-10 spacer sequence that is essential for optimal activity. FEMS Microbiol Lett (2009) 0.78
Lyme disease: a unique human model for an infectious etiology of rheumatic disease. Yale J Biol Med (1985) 0.78
Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol (1989) 0.77
Lyme arthritis in Europe: comparisons with reports from North America. Ann Rheum Dis (1988) 0.77
Distribution of antibodies reactive to Borrelia lonestari and Borrelia burgdorferi in white-tailed deer (Odocoileus virginianus) populations in the eastern United States. Vector Borne Zoonotic Dis (2009) 0.77
Complete heart block in a 9 year old girl caused by borreliosis. Br Heart J (1993) 0.75
Misdiagnosis of early Lyme disease as the summer flu. Orthop Rev (Pavia) (2011) 0.75
Lyme disease. West J Med (1984) 0.75
National survey of state epidemiologists to determine the status of Lyme disease surveillance. Public Health Rep (1993) 0.75
The use of deer vehicle accidents as a proxy for measuring the degree of interaction between human and deer populations and its correlation with the incidence rate of Lyme disease. J Environ Health (2013) 0.75
IgG subclasses of specific antibodies in Ixodes ricinus-borne borreliosis. Clin Exp Immunol (1987) 0.75
Erythema chronicum migrans. J R Soc Med (1987) 0.75
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum (1977) 9.14
Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med (1976) 7.00
Western blotting in the serodiagnosis of Lyme disease. J Infect Dis (1993) 6.45
Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science (1981) 6.34
The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest (1986) 5.72
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol (1971) 5.41
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78
Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med (1979) 4.73
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3. J Immunol (1969) 4.38
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med (2001) 4.35
The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes. J Clin Invest (1967) 4.22
Mechanism of interaction between Ku protein and DNA. J Biol Chem (1986) 4.22
Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med (1980) 4.12
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis (1988) 4.08
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07
Microtubular crystals in mammalian cells. J Cell Biol (1969) 3.98
Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. J Exp Med (1973) 3.83
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med (1998) 3.62
The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55
Chronic neurologic manifestations of Lyme disease. N Engl J Med (1990) 3.54
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis. J Immunol (1968) 3.24
Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J Exp Med (1996) 3.23
Properdin factor D: characterization of its active site and isolation of the precursor form. J Exp Med (1974) 3.21
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component. J Immunol (1967) 3.18
The complement system of man. I. N Engl J Med (1972) 3.09
Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun (1993) 3.04
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02
Antibiotic therapy in Lyme disease. Ann Intern Med (1980) 2.93
Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages. Yale J Biol Med (1971) 2.91
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91
Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med (1991) 2.91
Treatment of the early manifestations of Lyme disease. Ann Intern Med (1983) 2.89
Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem (1986) 2.79
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science (1976) 2.70
Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem (1993) 2.66
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks. Science (1990) 2.58
Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin. J Immunol (1979) 2.58
Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun (1994) 2.57
Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol (1978) 2.53
The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids. Arthritis Rheum (1971) 2.53
Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med (1993) 2.52
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50
The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum (1986) 2.49
Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Microtubule crystals: a new biophysical phenomenon induced by Vinca alkaloids. Nature (1968) 2.41
Diagnosing early Lyme disease. Am J Med (1985) 2.41
Handwashing practices for the prevention of nosocomial infections. Ann Intern Med (1975) 2.36
Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Properdin factor D. II. Activation to D by properdin. J Exp Med (1974) 2.19
Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science (1968) 2.19
Treatment of early Lyme disease. Am J Med (1992) 2.18
Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein. Immunology (1970) 2.17
Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci (1988) 2.16
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05
Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03
Congenital heart block in newborns of mothers with connective tissue disease. Circulation (1977) 2.02
Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum (1999) 2.01
DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci U S A (1994) 2.01
Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95
Structural polymorphism of the fourth component of human complement. J Clin Invest (1969) 1.91
Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol (1992) 1.89
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis (1993) 1.88
Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med (1974) 1.88
The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli. J Immunol (1969) 1.87
High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol (1988) 1.86
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
The mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis. J Cell Biol (1972) 1.84
Pathophysiology of small intestinal malabsorption in gerbils infected with Giardia lamblia. Gastroenterology (1992) 1.82
Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis (2000) 1.82